Matthew Nicosia - Jun 9, 2022 Form 4 Insider Report for Vivakor, Inc. (VIVK)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Matthew Nicosia
Stock symbol: VIVK
Transactions as of: Jun 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/13/2022, 08:19 PM
Previous filing: Feb 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIVK	Stock Option to Purchase Common Stock	Award	$0	+955K		$0.00	955K	Jun 9, 2022	Common Stock	955K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Matthew Nicosia. Pursuant to the Agreement, the Company granted Mr. Nicosia a stock option to acquire 955,053 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 278,356 of the shares vesting immediately, 225,579 of the shares vesting three (3) months after issuance, and the remaining 451,158 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (64,451 for 6 quarters and 64,642 in the last quarter), with an exercise price equal to 110% of the fair market value on the date grant, and which expires five (5) years after the date of grant.

Content

On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Matthew Nicosia. Pursuant to the Agreement, the Company granted Mr. Nicosia a stock option to acquire 955,053 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 278,356 of the shares vesting immediately, 225,579 of the shares vesting three (3) months after issuance, and the remaining 451,158 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (64,451 for 6 quarters and 64,642 in the last quarter), with an exercise price equal to 110% of the fair market value on the date grant, and which expires five (5) years after the date of grant.